GB1451798A - Prostanoic acid derivatives - Google Patents

Prostanoic acid derivatives

Info

Publication number
GB1451798A
GB1451798A GB3669173A GB3669173A GB1451798A GB 1451798 A GB1451798 A GB 1451798A GB 3669173 A GB3669173 A GB 3669173A GB 3669173 A GB3669173 A GB 3669173A GB 1451798 A GB1451798 A GB 1451798A
Authority
GB
United Kingdom
Prior art keywords
trimethylsilyloxy
cis
acid derivatives
tetranor
vinylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3669173A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB3669173A priority Critical patent/GB1451798A/en
Priority to AR255032A priority patent/AR204013A1/es
Priority to IE1472/74A priority patent/IE40157B1/xx
Priority to US05/488,759 priority patent/US3954881A/en
Priority to ZA00744509A priority patent/ZA744509B/xx
Priority to IN1602/CAL/74A priority patent/IN138940B/en
Priority to IL45299A priority patent/IL45299A/xx
Priority to ZM120/74A priority patent/ZM12074A1/xx
Priority to AU71635/74A priority patent/AU482077B2/en
Priority to NO742713A priority patent/NO742713L/no
Priority to DD180228A priority patent/DD114401A5/xx
Priority to DK410174*A priority patent/DK410174A/da
Priority to LU70639A priority patent/LU70639A1/xx
Priority to CH1055174A priority patent/CH605511A5/xx
Priority to NL7410343A priority patent/NL7410343A/xx
Priority to BE147209A priority patent/BE818396A/xx
Priority to CS5488A priority patent/CS174785B2/cs
Priority to SE7409930A priority patent/SE7409930L/xx
Priority to FR7426759A priority patent/FR2239995B1/fr
Priority to DE2437388A priority patent/DE2437388A1/de
Priority to JP49088920A priority patent/JPS5069045A/ja
Priority to AT635674A priority patent/AT341119B/de
Priority to FI2322/74A priority patent/FI232274A7/fi
Priority to ES428889A priority patent/ES428889A1/es
Priority to EG316/74A priority patent/EG11489A/xx
Publication of GB1451798A publication Critical patent/GB1451798A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB3669173A 1973-08-02 1973-08-02 Prostanoic acid derivatives Expired GB1451798A (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB3669173A GB1451798A (en) 1973-08-02 1973-08-02 Prostanoic acid derivatives
AR255032A AR204013A1 (es) 1973-08-02 1974-01-01 Proceso para fabricar un derivado de 1-alcoxi-16-clorofenoxi-17,18,19,20-tetranor-5-cis-13-trans-prostadien-9 alfa 11 alfa 15-triol
IE1472/74A IE40157B1 (en) 1973-08-02 1974-07-12 Prostanoic acid derivatives
US05/488,759 US3954881A (en) 1973-08-02 1974-07-15 Prostanoic acid derivatives
ZA00744509A ZA744509B (en) 1973-08-02 1974-07-15 Prostanoic acid derivatives
IN1602/CAL/74A IN138940B (enExample) 1973-08-02 1974-07-18
IL45299A IL45299A (en) 1973-08-02 1974-07-18 16-phenoxy-11a,15a-dihydroxy-17,18,19,20-tetranor-5-cis-13-transprostadienoic acid and prostadienol derivatives and prostadienol derivatives and processes for their preparation
ZM120/74A ZM12074A1 (en) 1973-08-02 1974-07-23 Prostanoic acid derivatives
AU71635/74A AU482077B2 (en) 1973-08-02 1974-07-25 Prostanoic acid derivatives
NO742713A NO742713L (enExample) 1973-08-02 1974-07-25
DD180228A DD114401A5 (enExample) 1973-08-02 1974-07-31
DK410174*A DK410174A (enExample) 1973-08-02 1974-07-31
LU70639A LU70639A1 (enExample) 1973-08-02 1974-07-31
CH1055174A CH605511A5 (enExample) 1973-08-02 1974-07-31
NL7410343A NL7410343A (nl) 1973-08-02 1974-08-01 Werkwijze voor de bereiding van prostaanzuur derivaten.
BE147209A BE818396A (fr) 1973-08-02 1974-08-01 Derives de l'acide prostanoique
CS5488A CS174785B2 (enExample) 1973-08-02 1974-08-01
SE7409930A SE7409930L (enExample) 1973-08-02 1974-08-01
FR7426759A FR2239995B1 (enExample) 1973-08-02 1974-08-01
DE2437388A DE2437388A1 (de) 1973-08-02 1974-08-02 Prostansaeurederivate
JP49088920A JPS5069045A (enExample) 1973-08-02 1974-08-02
AT635674A AT341119B (de) 1973-08-02 1974-08-02 Verfahren zur herstellung von neuen prostanderivaten
FI2322/74A FI232274A7 (enExample) 1973-08-02 1974-08-02
ES428889A ES428889A1 (es) 1973-08-02 1974-08-02 Procedimiento de preparacion de derivados de acido prosta- noico.
EG316/74A EG11489A (en) 1973-08-02 1974-08-03 Process for preparing of prostanoic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3669173A GB1451798A (en) 1973-08-02 1973-08-02 Prostanoic acid derivatives

Publications (1)

Publication Number Publication Date
GB1451798A true GB1451798A (en) 1976-10-06

Family

ID=10390378

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3669173A Expired GB1451798A (en) 1973-08-02 1973-08-02 Prostanoic acid derivatives

Country Status (24)

Country Link
US (1) US3954881A (enExample)
JP (1) JPS5069045A (enExample)
AR (1) AR204013A1 (enExample)
AT (1) AT341119B (enExample)
BE (1) BE818396A (enExample)
CH (1) CH605511A5 (enExample)
CS (1) CS174785B2 (enExample)
DD (1) DD114401A5 (enExample)
DE (1) DE2437388A1 (enExample)
DK (1) DK410174A (enExample)
EG (1) EG11489A (enExample)
ES (1) ES428889A1 (enExample)
FI (1) FI232274A7 (enExample)
FR (1) FR2239995B1 (enExample)
GB (1) GB1451798A (enExample)
IE (1) IE40157B1 (enExample)
IL (1) IL45299A (enExample)
IN (1) IN138940B (enExample)
LU (1) LU70639A1 (enExample)
NL (1) NL7410343A (enExample)
NO (1) NO742713L (enExample)
SE (1) SE7409930L (enExample)
ZA (1) ZA744509B (enExample)
ZM (1) ZM12074A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives
US4183870A (en) * 1974-01-26 1980-01-15 May & Baker Limited Cyclopentane derivatives
GB1506817A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
US4388457A (en) * 1982-02-11 1983-06-14 University Patents, Inc. Phyllanthostatin compounds
AU623764B2 (en) * 1989-03-28 1992-05-21 Abbott Laboratories Erythromycin derivatives
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6184250B1 (en) 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5721273A (en) 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
ATE237587T1 (de) * 1997-02-10 2003-05-15 Ono Pharmaceutical Co 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten
EP1435972B1 (en) * 2001-08-29 2016-03-09 Seneb Biosciences Inc. Novel synthetic ganglioside derivatives and compositions thereof
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
EP1771066A2 (en) 2004-07-13 2007-04-11 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1
DK2586456T3 (en) 2004-10-29 2016-03-21 Ratiopharm Gmbh Conversion and glycopegylation of fibroblast growth factor (FGF)
EP1814569A2 (en) * 2004-11-09 2007-08-08 Neose Technologies, Inc. Glycolipids
WO2006074467A2 (en) 2005-01-10 2006-07-13 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
JP2010523582A (ja) 2007-04-03 2010-07-15 バイオジェネリクス アクチェンゲゼルシャフト グリコｐｅｇ化ｇ−ｃｓｆを用いた治療方法
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
RU2573587C2 (ru) 2008-02-27 2016-01-20 Ново Нордиск А/С Конъюгированные молекулы фактора viii
EP2410846B1 (en) 2009-03-25 2016-09-07 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1334952A (en) * 1971-01-06 1973-10-24 Ici Ltd Cyclopentane derivat-ves and a process for their manufacture

Also Published As

Publication number Publication date
ES428889A1 (es) 1976-09-01
AR204013A1 (es) 1975-11-12
NL7410343A (nl) 1975-02-04
LU70639A1 (enExample) 1974-12-10
FI232274A7 (enExample) 1975-02-03
DE2437388A1 (de) 1975-02-13
ZA744509B (en) 1975-07-30
CS174785B2 (enExample) 1977-04-29
IE40157L (en) 1975-02-02
ATA635674A (de) 1977-05-15
ZM12074A1 (en) 1976-11-22
JPS5069045A (enExample) 1975-06-09
BE818396A (fr) 1975-02-03
AT341119B (de) 1978-01-25
EG11489A (en) 1978-06-30
US3954881A (en) 1976-05-04
AU7163574A (en) 1976-01-29
IE40157B1 (en) 1979-03-28
IL45299A (en) 1978-06-15
DK410174A (enExample) 1975-04-01
NO742713L (enExample) 1975-03-03
SE7409930L (enExample) 1975-02-03
FR2239995B1 (enExample) 1978-07-21
FR2239995A1 (enExample) 1975-03-07
CH605511A5 (enExample) 1978-09-29
IN138940B (enExample) 1976-04-17
DD114401A5 (enExample) 1975-08-05
IL45299A0 (en) 1974-10-22

Similar Documents

Publication Publication Date Title
GB1451798A (en) Prostanoic acid derivatives
GB1409843A (en) Prostaglandin intermediates
GB1522686A (en) 1-(bis-trifluoromethylphenyl)-2-oxo-pyrrolidine-4-carboxylic acid derivatives their production and their use as plantgrowth regulators and herbicides
GB1520522A (en) 16-methyleneprostaglandins
GB1489778A (en) Process of preparing a stable composition containing a compound of the prostaglandin e group
GB1488006A (en) Prostaglandin analogues
IE37909L (en) Prostaglandin analogues
GB1299136A (en) Improvements in or relating to prostaglandins and the preparation thereof
GB1516181A (en) Cosmetic composition containing serine
GB1483240A (en) Prostaglandin analogues
GB1490634A (en) 7-amino-cephem compounds
IE38515L (en) Cyclopentane (prostanoic acid) derivatives
GB1449882A (en) Prostaglandin analogues
GB1517562A (en) Prostane derivatives
GB1444971A (en) Derivatives of prostanoic acid
GB1403501A (en) Prostaglandins and the preparation thereof
GB1524574A (en) Process for the manufacture of prostaglandins
IE43930L (en) Prostane derivatives
GB1449914A (en) 2,2, 10beta, 17 alpha-tetramethyl steroids a process for their preparation and compositions containing them
GB1482532A (en) Method for producing cephem derivatives
GB1435757A (en) Cyclopentane derivatives
GB1473670A (en) Process for the manufacture of prostaglandin-f2a and analogues thereof
GB1535780A (en) 16-aryloxy-17,18,19,20-tetranoprostanoic acid and derivatives
GB1292580A (en) Alkoxysilyl-substituted epoxidised urea derivatives
GB1464471A (en) Prostaglandin analogues

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee